What is Evommune 's derivative liability?

Evommune (EVMN) reported derivative liability of $3.32M in Q4 2025.

What does derivative liability mean?

Represents the fair value of financial instruments or embedded derivatives that the company is obligated to settle in cash or shares. These liabilities often arise from complex financing arrangements, such as convertible debt or warrants. High levels of derivative liabilities can indicate potential future dilution or significant cash volatility based on stock price movements.

Evommune EVMN Derivative Liability

Derivative Liability at other companies

Carrier GlobalCARR

$153M—

Apollo Global ManagementAPO

$19.43B+37.5%

Wells Fargo & CompanyWFC

$14.49B+30.4%

PNC Financial ServicesPNC

$1.82B-23.3%

State StreetSTT

$4.97B—

American International GroupAIG

$94M+16.0%

Other financials

Income statement

See full

Revenue$1.6M+3.5%

Gross profit$961.1K+10.9%

Operating income-$682.8K-2,027%

Net income-$7.0M-5,414%

EPS (diluted)-$0.36-1,700%

Balance sheet

See full

Cash & equivalents$1.1M+401%

Total debt$2.0M—

Total equity-$4.5M-3,048%

Total assets$7.2M—

Cash flow

See full

Operating cash flow-$424.6K-341%

CapEx$1.0-99.8%

Free cash flow-$2.7M-4,996%

Valuation

See full

Market cap$848.59M+39.5%

Enterprise value$849.52M—

P/S127.3×—

Profitability

See full

Gross margin53.7%—

Operating margin-30.7%—

Net margin-90.1%—

Returns & leverage

See full

Return on equity275.7%—

Debt / equity1.4×—

Current ratio1.2×—

Where this comes from

Reported directly by Evommune in its filing.

Tagged under the XBRL concept meha:DerivativeLiability.

The official record: Evommune ’s 10-K, filed March 27, 2026, on SEC EDGAR. View the filing →

Ask your AI about Evommune 's derivative liability.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Evommune 's derivative liability?: Evommune (EVMN) reported derivative liability of $3.32M in Q4 2025.
What does derivative liability mean?: Represents the fair value of financial instruments or embedded derivatives that the company is obligated to settle in cash or shares. These liabilities often arise from complex financing arrangements, such as convertible debt or warrants. High levels of derivative liabilities can indicate potential future dilution or significant cash volatility based on stock price movements.